Alnylam Pharmaceuticals (ALNY) Q1 2026 Earnings

Feb 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.89
0.02
0.93
1.84

Details

Expected EPS
1.15591
Actual EPS
0.82
Surprise EPS
-0.34
Surprise Percent
-29.06%

Description

⁨Alnylam Pharmaceuticals⁩ (⁦ALNY⁩) has reported earnings of ⁦0.82⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts